MatthewHartingMDMS

General Surgery • Houston, TX

Pediatric General Surgery, Trauma Surgery & Surgical Critical Care

Assistant Professor, Department of Pediatric Surgery, University of Texas Medical School at Houston

Join to view full profile

Dr. Harting is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Harting's full profile

Already have an account?

Office
6410 Fannin St
Suite 950
Houston, TX 77030
Phone+1 832-325-7234

Summary

Dr. Matthew Harting is an assistant professor in the Department of Pediatric Surgery. He is certified by the American Board of Surgery in general surgery, pediatric surgery and surgical critical care. A Texas native, Dr. Harting grew up in the Austin area and received his undergraduate degree from the University of Texas at Austin in the Dean’s Scholars Honors program in the College of Natural Sciences. He received his medical degree, as well as a master of science in clinical research, from the University of Texas Medical School at Houston, and completed his surgical residency at the University of Michigan. During his surgical training, he completed an NIH T32 and T15 sponsored clinical, translational, and basic science research fellowship in adult stem cell therapies and trauma. An additional post-graduate fellowship was completed in Pediatric Surgery at the University of Washington Seattle Children’s Hospital and he completed a Surgical Critical Care fellowship at the University of Texas Medical School at Houston.

Dr. Harting’s clinical interests include congenital and acquired thoracic disease, including pulmonary, diaphragmatic, and esophageal disease. He has particular interest in patients with congenital diaphragmatic hernias. He also has interest in minimally invasive surgery and extracorporeal life support (ELS or ECMO).

Dr. Harting is a clinical and basic-translational scientist with interests in pulmonary disease and stem cell biology. His primary research is focused on congenital diaphragmatic hernia and the concomitant pulmonary pathophysiology. He is investigating novel, cell-based therapies as treatment strategies for congenital pulmonary disease. Additionally, he is involved in the Center for Surgical Trials and Evidence Based Practice.

Education & Training

University of Texas Health Science Center at HoustonResidency, Surgical Critical Care, 2013 - 2014
University of WashingtonFellowship, Pediatric Surgery, 2013
University of MichiganResidency, Surgery, 2008 - 2011
University of Texas Health Science Center at HoustonResidency, Surgery, 2004 - 2008
University of Texas, Schools of Medicine and Public HealthM.Sc., Clinical Research, 1999 - 2003
McGovern Medical School at UTHealthClass of 2003
The University of Texas at AustinB.A., Microbiology, 1995 - 1999

Certifications & Licensure

TX State Medical License 2013 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
WA State Medical License 2011 - 2013
MI State Medical License 2008 - 2011
American Board of Surgery Surgery
American Board of Surgery Pediatric Surgery
American Board of Surgery Surgical Critical Care

Awards, Honors, & Recognition

Golden Beeper Award, Awarded to the Most Outstanding Resident Teacher Michigan Alumni Society, 2011
Residents Surgeon Competition, Committee on Trauma Clinical Award Michigan Chapter – American College of Surgeons, 2010
Frederick A. Coller Clinical Tour Award, Educational, Clinical, and Research Week-long Travel Opportunity 2009
Arnold G. Coran Teaching Award, The Annual Surgery Award for Excellence in Teaching – Senior Resident 2009, 2011
Bronze Beeper Award, Awarded for Outstanding Resident Teaching Michigan Alumni Society, 2009, 2011
Alpha Omega Alpha Honor Medical Society Delta Chapter University of Texas Medical School, 2006
T15 Adult Stem Cell Training Grant Award Recipient National Institute of Health, 2006
T32 National Trauma Research Service Award recipient National Institute of Health, 2006
College Scholar Award College of Natural Sciences, University of Texas at Austin, 1998
Dean’s Scholars Honors Program, College of Natural Sciences University of Texas at Austin, 1995
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH) Start of enrollment: 2018 Aug 01
Recruiting
Phase 1
Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The "NoNO Trial" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative Start of enrollment: 2025 Jan 01
Not yet recruiting
Phase 4
Roles: Principal Investigator

Publications & Presentations

PubMed

71 citations
Purinergic Signaling in Pulmonary Inflammation.
Thanh Thuy T. Le, Nathaniel K. Berg, Matthew T. Harting, Xiangyun Li, Holger K. Eltzschig
Frontiers in Immunology. 2019-07-16
37 citations
Management of Congenital Diaphragmatic Hernia Treated With Extracorporeal Life Support: Interim Guidelines Consensus Statement From the Extracorporeal Life Support Org...
Yigit S. Guner, Tim Jancelewicz, Matteo Di Nardo, Peter T. Yu, Mary Brindle
ASAIO Journal. 2021-02-01
5 citations
Impact of Repeat Extracorporeal Life Support on Mortality and Short-term In-hospital Morbidities in Neonates With Congenital Diaphragmatic Hernia.
Enrico Danzer, Matthew T Harting, Alex Dahlen, Carmen Mesas Burgos, Björn Frenckner
Annals of Surgery. 2023-09-01

Journal Articles

Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children
Cox CS, Baumgartner JE, Harting MT, Worth LL, Walker PA, Shah SK, Ewing-Cobbs L, Hasan KM, Day MC, Lee D, Jimenez F, Gee A, Neurosurgery, 1/1/2011
Progenitor cell therapy for the treatment of central nervous system injury: a review of the state of current clinical trials
Walker PA, Harting MT, Shah SK, Day MC, Khoury RE, Savitz SI, Baumgartner J, Cox CS, Stem Cells Int, 1/1/2010
Current trends in cell therapy for pediatric acquired brain injury
Walker PA, Harting MT, Shah SK, Cox CS, Minerva Pediatrica, 1/1/2010
Congenital diaphragmatic hernia in the preterm infant
Tsao K, Allison ND, Harting MT, Lally PA, Lally KP, Surgery, 1/1/2010
Effect of needle diameter and flow rate on rat and human mesenchymal stromal cell characterization and viability
Walker PA, Jimenez F, Gerber MH, Aroom KR, Shah SK, Harting MT, Gill BS, Savitz SI, Cox CS, Tissue Engineering, 1/1/2010
Age as a prognostic factor among patients with osteosarcoma: Analysis of 438 patients
Harting MT, Lally KP, Andrassy RJ, Vaporciyan AA, Cox CS, Hayes- Jordan A, Blakely ML, J Cancer Res Clin Oncol, 1/1/2010
Direct intrathecal implantation of mesenchymal stromal cells leads to enhance neuroprotection via an NF-kappa B-mediated increase in IL-6 production
Walker PA, Harting MT, Jimenez F, Shah SK, Pati S, Dash PK, Cox CS, Stem Cells Dev, 1/1/2010
Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect
Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Laine GA, Cox CS, Stem Cells Dev, 1/1/2009
Modern approaches to pediatric brain injury therapy
Walker PA, Harting MT, Baumgartner JE, Fletcher S, Strobel N, Cox CS, J Trauma, 1/1/2009
Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation
Walker PA, Shah SK, Harting MT, Cox CS, Dis Model Mech, 1/1/2009
Bone marrow-derived mononuclear cell populations in pediatric and adult patients
Harting MT, Cox CS, Day MC, Walker P, Gee A, Brenneman MM, Grotta JC, Savitz SI, Cytotherapy, 1/1/2009
Subacute neural stem cell therapy for traumatic brain injury
Harting MT, Sloan LE, Jimenez F, Baumgartner J, Cox CS, J Surg Res, 1/1/2009
Intravenous mesenchymal stem cell therapy for traumatic brain injury
Harting MT, Jimenez F, Xue H, Fischer U, Baumgartner J, Dash PK, Cox CS, J Neurosurg, 1/1/2009
Bioimpedance analysis: A guide to simple design and implementation
Aroom K, Harting MT, Cox CS, Radhakrishnan RS, Smith CT, Gill B, J Surg Res, 1/1/2009
Isolation of mesenchymal stem cells (MSCs) from green fluorescent protein positive (GFP+) transgenic rodents: the grass is not always green(er)
Harting MT, Jimenez F, Cox CS, Stem Cells Dev, 1/1/2009
Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy
Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS, Surgery, 1/1/2008
The pulmonary first-pass effect, xenotransplantation, and translation to clinical trials – a commentary
Harting MT, Jimenez F, Cox CS, Brain, 1/1/2008
Cell therapies for traumatic brain injury
Harting MT, Baumgartner JE, Worth LL, Ewing-Cobbs L, Gee AP, Day MC, Cox CS, Neurosurg Focus, 1/1/2008
Pretreatment with bone morphogenetic protein-7 (BMP7) mimics ischemia preconditioning (IPC) following intestinal ischemia/reperfusion (IR) injury in the intestine and ...
Radhakrishnan RS, Radhakrishnan GL, Radhakrishnan HR, Xue H, Adams SD, Moore-Olufemi SD, Harting MT, Cox CS, Kone BC, Shock, 1/1/2008
Immunophenotype characterization of rat mesenchymal stromal cells
Harting MT, Jimenez F, Pati S, Baumgartner J, Cox CS, Cytotherapy, 1/1/2008
Acute hemodynamic decompensation following patent ductus arteriosus ligation in premature infants
Harting MT, Blakely ML, Cox CS, Lantin-Hermoso R, Andrassy RJ, Lally KP, J Invest Surg, 1/1/2008
Effects of Poloxamer 188 on human PMN cells
Harting MT, Jimenez F, Kozar RA, Moore FA, Mercer DW, Hunter RL, Cox CS, Gonzalez EA, Surgery, 1/1/2008
Surgical management of neonates with congenital diaphragmatic hernia
Harting MT, Lally KP, Seminars in Pediatric Surgery, 1/1/2007
Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma
Harting MT, Blakely ML, Jaffe N, Cox CS Jr, Hayes-Jordan A, Benjamin RS, Raymond AK, Andrassy RJ, Lally KP, J Pedi Surg, 1/1/2006
Management of osteosarcoma pulmonary metastases
Harting MT, Blakely ML, Seminars in Pediatric Surgery, 1/1/2006
Join now to see all

Books/Book Chapters

Progenitor Cell Therapy for Neurological Injury
Chapter: Chapter 1: Basics of stem and progenitor cells.
Page 1 - 36Harting MTEditors: Cox CS.2010
Regulatory Networks in Stem Cells.
Chapter: Chapter 42. Preclinical evidence for cellular therapy as a treatment for neurological disease.
Page 561 - 573Harting MT, Cox CS, Hall SEditors: Rajasekhar VK, Vemuri MC.Humana Press Inc2009
Reoperative Pediatric Surgery.
Chapter: Chapter 26. Osteosarcoma metastases.
Page 435 - 446Harting MT, Andrassy RJ, Hayes-Jordan AEditors: Caniano D and Teich S.Humana Press Inc2008
In Heart failure in children and young adults.
Chapter: The future of ventricular assistance in children and young adults. Chapter 50.
Page 700 - 706Harting MT, Frazier OHElsevier Inc., Philadelphia, PA2006
Pediatric Surgery
Chapter: Rhabdomyosarcoma. Chapter 70.
Page 1019 - 1027Blakely ML, Harting MT, Andrassy RJEditors: Ashcraft KW, Holcomb GW III, Murphy JP.Elsevier Inc., Philadelphia, PAEdition 4th,2005
Join now to see all

Abstracts/Posters

Intussusception of bypassed ileal segment following ileal exclusion for progressive familial intrahepatic cholestasis.
Ricca RL, Harting MT, Healey PJ, Javid PJ, Journal of Pediatric Surgery Case Reports, 1/1/2014
Intravenously administered mononuclear cells pass through the pulmonary barrier and enhance recovery after ischemic stroke.
Savitz SI, Fischer UM, Harting MT, Grotta JC, Cox CS, International Stroke Conf, American Heart Association, San Diego, CA, 1/1/2009
Autologous bone marrow mononuclear cells enhance recovery after ischemic stroke in young and middle aged rats.
Savitz SI, Strong R, Harting MT, Brenneman M, Cox CS, Grotta JC, International Stroke Conf, American Heart Association, San Diego, CA, 1/1/2009
Autologous mononuclear cells enhance angiogenesis and reduce inflammation after ischemic stroke. Poster
Savitz SI, Harting MT, Brenneman M, Cox CS, Grotta JC, International Stroke Conf, American Heart Association, San Diego, CA, 1/1/2009
Walker PA, Harting MT, Jimenez F, Pati S, Dash PK, Cox CS, Surgical Forum Program, American College of Surgeons, Chicago, IL, 1/1/2009
Phase I clinical trial of autologous bone marrow mononuclear cells for pediatric severe traumatic brain injury.
Cox CS, Baumgartner JE, Worth L, Harting MT, EwingCobbs L, Gee A, Hasan K, Shah S, Walker P, Day M, Annual Meeting, Congress of Neurosurgical Surgeons, New Orleans, LA, 1/1/2009
Ketamine does not exacerbate traumatic brain injury induced inflammation in the rat.
Harting MT, Ward JL, Helmer KS, Cox CS, Mercer DA, Shock Society, Cologne, Germany, 1/1/2008
Lobectomy for pulmonary metastasis in pediatric osteosarcoma: Futility or utility?
Letourneau PA, Harting MT, Andrassy RJ, Lally KP, Cox CS, Hayes-Jordan AA, American Academy of Pediatrics, Surgical Section, Boston, MA, 1/1/2008
Mesenchymal stem cell therapy for traumatic brain injury: Implications for intracranial inflammation.
Harting MT, Pati S, Jimenez F, Dash PK, Cox CS, Surgical Forum Program, American College of Surgeons, San Francisco, CA, 1/1/2008
No differences in mononuclear cells derived from pediatric versus older patients. Poster
Harting MT, Perin EC, Willerson JT, Grotta J, Gee A, Cox CS, Savitz SI, International Society for Stem Cell Research, Philadelphia, PA, 1/1/2008
Pulmonary passage is a major obstacle for efficient intravenous stem cell delivery. Poster
Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Laine GA, Cox CS, International Society for Stem Cell Research, Philadelphia, PA, 1/1/2008
Mesenchymal stem cell expression of green fluorescent protein after isolation from transgenic rodents. Poster
Harting MT, Jimenez F, Cox CS, International Society for Stem Cell Research, Philadelphia, PA, 1/1/2008
Intravenous rodent mesenchymal stem cell therapy for traumatic brain injury? Poster
Harting MT, Jimenez F, Xue H, Fischer U, Baumgartner J, Dash PK, Cox CS, International Society for Stem Cell Research, Philadelphia, PA, 1/1/2008
Outcome of non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) in children and adolescents: Does age matter?
Hayes-Jordan A, Maldonado Y, Xiao LC, Cormier J, Lazar A, Harting MT, Herzog C, Huh W, Pisters P, Society of Surgical Oncology, Chicago, IL, 1/1/2008
Subacute neural stem cell therapy for traumatic brain injury.
Sloan LE, Harting MT, Jimenez F, Baumgartner J, Cox CS, Academic Surgical Congress, Plenary Session, Huntington Beach, CA, 1/1/2008
Direct effects of poloxamer 188 on human PMN cells.
Harting MT, Jimenez F, Kozar RA, Moore FA, Mercer DW, Hunter RL, Cox CS, Gonzalez, EA, Academic Surgical Congress (SUS), Trauma/Critical Care Section, Huntington Beach, CA, 1/1/2008
Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy.
Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS, Academic Surgical Congress (SUS), Trauma/Critical Care Section, Huntington Beach, CA, 1/1/2008
Transcriptional profile analysis of acute intestinal edema after treatment with hypertonic saline.
Harting MT, Radhakrishnan RS, Moore-Olufemi SD, Cox CS, Academic Surgical Congress (SUS), Trauma/Critical Care Section, Huntington Beach, CA, 1/1/2008
Measurement of cerebral edema after traumatic brain injury using impedance analysis.
Harting MT, Smith CT, Radhakrishnan RS, Dash PK, Gill B, Cox CS, Surgical Forum Program, Critical Care Section, American College of Surgeons, New Orleans, LA, 1/1/2007
Massive nodular melanoma: A case report.
Harting MS, Tarrant W, Kovitz CA, Rosen T, Harting MT, Souchon EA, Dermatol Online J, 1/1/2007
Does age influence outcome among patients with osteosarcoma? Poster
Harting MT, Blakely ML, Hayes-Jordan A, Andrassy RJ, Lally KP, American Pediatric Surgical Association, Hilton Head, SC, 1/1/2006
Modified pyloric exclusion for infants with complex duodenal injuries.
Harting MT, Doherty D, Lally KP, Andrews WM, Cox CS, Pediatr Surg Int, 1/1/2005
Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
Harting MT, Blakely ML, Jaffe N, Cox CS, Hayes-Jordan A, Benjamin RS, Raymond AK, Andrassy RJ, Lally KP, American Pediatric Surgical Association, Phoenix, AZ, 1/1/2005
Cardiac decompensation after patent ductus arteriosus ligation in premature infants.
Harting MT, Lally KP, Cox CS, Lantin-Hermoso R, Blakely ML, American Academy of Pediatrics, San Francisco, CA, 1/1/2004
Sarcoma metastatic to the right ventricle: surgical intervention followed by prolonged survival.
Harting MT, Messner GN, Gregoric ID, Frazier OH, Tex Heart Inst J, 1/1/2004
Join now to see all

Press Mentions

Research Study Invitation – Your Data Helps the CDH Study GroupAugust 22nd, 2022
Study Finds Telemedicine Appointments Reduce Risk of Further IllnessAugust 30th, 2021
Scientists May Have Figured Out Why Children Less Likely to Have Severe COVID-19 SymptomsDecember 12th, 2020
Join now to see all